Astellas Pharma gets US regulator’s nod for its gastric cancer drug
Astellas Pharma Inc.’s therapy to treat a form of gastric cancer got approval from the US drug regulator, according to a company statement.
Drugs
Health
Pharma
Drugs
Health
Pharma
Merck’s Keytruda experimental gastric cancer drug flops in one of set goals
HQ Team June 20, 2023: Merck Group’s investigational drug Keytruda, to treat gastric cancer, has failed to meet one of its two set.
Drugs
Pharma
Moderna-Merck’s cancer vaccine gets FDA breakthrough therapy designation
Moderna Inc., a biotechnology company, and Merck announced that an experimental personalised cancer vaccine, based on the messenger RNA (mRNA) technology, has received.